🇺🇸 FDA
Patent

US 11305009

Recombinant virus with diminished latency and methods of using same

granted A61KA61K2039/5254A61K39/12

Quick answer

US patent 11305009 (Recombinant virus with diminished latency and methods of using same) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K2039/5254, A61K39/12, A61K39/245, A61K39/25